These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6150500)

  • 21. Prolactin releasing potencies of antipsychotic and related nonantipsychotic compounds in female rats: relation to clinical potencies.
    Hays SE; Poland RE; Rubin RT
    J Pharmacol Exp Ther; 1980 Aug; 214(2):362-7. PubMed ID: 6104725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal effects of JL 13, a pyridobenzoxazepine derivative with an antipsychotic potential, on circulating prolactin levels in male rats.
    Liégeois JF; Bruhwyler J; Hendrick JC; Delarge J; Legros JJ; Damas J
    Neurosci Lett; 2002 Feb; 319(1):49-52. PubMed ID: 11814651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of acute administration of zetidoline, a new antidopaminergic drug, on plasma prolactin and aldosterone levels in man.
    Barbieri C; Parodi M; Bruno S; Bertassi F; Benaglia D; Moser P; Meroni R; Dubini A
    Eur J Clin Pharmacol; 1984; 26(1):29-32. PubMed ID: 6143669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haloperidol-induced plasma prolactin release: sensitivity, reliability, and comparison to haloperidol antagonism of dopamine agonist-induced stereotyped behavior in the rat.
    Feigenbaum JJ; Moon BH; Catterton R; Yanai J; Klawans HL
    Psychopharmacology (Berl); 1982; 78(4):383-4. PubMed ID: 6818604
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of drugs infused into a rat hypophysial portal vessel on prolactin and growth hormone release.
    Abe H; Kato Y; Chihara K; Iwasaki Y; Imura H
    Proc Soc Exp Biol Med; 1980 Nov; 165(2):248-52. PubMed ID: 6160593
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of rat prolactin release by apomorphine in vivo and in vitro.
    Smalstig EB; Sawyer BD; Clemens JA
    Endocrinology; 1974 Jul; 95(1):123-9. PubMed ID: 4857693
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of L-dopa and chlorpromazine on prolactin and growth hormone secretion in normal women.
    Leblanc H; Yen SS
    Am J Obstet Gynecol; 1976 Sep; 126(2):162-4. PubMed ID: 961756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor blockade by imidoline and its proposed active conformation.
    Koe BK; Koch SW; Dominy BW
    Eur J Pharmacol; 1980 Nov; 68(2):139-46. PubMed ID: 6110542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat.
    Kinon BJ; Merson D; Kane JM
    Psychopharmacology (Berl); 1984; 84(3):347-51. PubMed ID: 6440181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
    Obuchowicz E
    Neuropeptides; 1996 Oct; 30(5):471-8. PubMed ID: 8923510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity.
    Beal MF; Martin JB
    Neurosci Lett; 1984 Jun; 47(2):125-30. PubMed ID: 6146954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
    Bowden CR; Voina SJ; Woestenborghs R; De Coster R; Heykants J
    J Pharmacol Exp Ther; 1992 Aug; 262(2):699-706. PubMed ID: 1380082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of prolactin secretion by neuroleptics in rats with medial basal hypothalamic lesions.
    Cheung CY; Neill AC; Weiner RI
    Neuroendocrinology; 1981 Jun; 32(6):370-4. PubMed ID: 6165920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroleptic drugs and 5HT1 receptor: different potencies of various neuroleptic drugs on 5HT1 receptors in discrete regions of the rat brain.
    Harada T; Sato M; Otsuki S
    Folia Psychiatr Neurol Jpn; 1985; 39(4):551-7. PubMed ID: 2870958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.